KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction

Biochemical and Biophysical Research Communications

Volumn 351, Issue 1, 2006, Pages 216-222

  Okamoto, Koji ^a,c   Kitabayashi, Issay ^b   Taya, Yoichi ^a,c  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Pediatric Oncology Division   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Actinomycin D; KAP1; Mdm2; p53

Indexed keywords

DACTINOMYCIN; PROTEIN; PROTEIN KAP1; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GAMMA IRRADIATION; GENE FUNCTION; GENE IDENTIFICATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN INTERACTION; REPRESSOR GENE;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DACTINOMYCIN; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; GAMMA RAYS; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MDM2; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33750373155     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.022     Document Type: Article

References (27)

1. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
2. Olivier M., Eeles R., Hollstein M., Khan M.A., Harris C.C., and Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum. Mutat. 19 (2002) 607-614
3. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2 (2002) 594-604
4. Juven-Gershon T., and Oren M. Mdm2: the ups and downs. Mol. Med. 5 (1999) 71-83
5. Prives C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95 (1998) 5-8
6. Lane D.P., and Hall P.A. MDM2-arbiter of p53's destruction. Trends Biochem. Sci. 22 (1997) 372-374
7. Stommel J.M., and Wahl G.M. A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation. Cell Cycle 4 (2005) 411-417
8. Ko L.J., and Prives C. p53: puzzle and paradigm. Genes Dev. 10 (1996) 1054-1072
9. Momand J., Wu H.H., and Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein. Gene 242 (2000) 15-29
10. Ito A., Kawaguchi Y., Lai C.H., Kovacs J.J., Higashimoto Y., Appella E., and Yao T.P. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21 (2002) 6236-6245
11. Kim S.S., Chen Y.M., O'Leary E., Witzgall R., Vidal M., and Bonventre J.V. A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc. Natl. Acad. Sci. USA 93 (1996) 15299-15304
12. Friedman J.R., Fredericks W.J., Jensen D.E., Speicher D.W., Huang X.P., Neilson E.G., and Rauscher III F.J. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 10 (1996) 2067-2078
13. Agata Y., Matsuda E., and Shimizu A. Two novel Kruppel-associated box-containing zinc-finger proteins, KRAZ1 and KRAZ2, repress transcription through functional interaction with the corepressor KAP-1 (TIF1β/KRIP-1). J. Biol. Chem. 274 (1999) 16412-16422
14. Schultz D.C., Friedman J.R., and Rauscher III F.J. Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD. Genes Dev. 15 (2001) 428-443
15. Underhill C., Qutob M.S., Yee S.P., and Torchia J. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J. Biol. Chem. 275 (2000) 40463-40470
16. Schultz D.C., Ayyanathan K., Negorev D., Maul G.G., and Rauscher III F.J. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16 (2002) 919-932
17. Wang C., Ivanov A., Chen L., Fredericks W.J., Seto E., Rauscher III F.J., and Chen J. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J. 24 (2005) 3279-3290
18. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., and Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102 (2000) 849-862
19. Okamoto K., Kashima K., Pereg Y., Ishida M., Yamazaki S., Nota A., Teunisse A., Migliorini D., Kitabayashi I., Marine J.C., Prives C., Shiloh Y., Jochemsen A.G., and Taya Y. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation. Mol. Cell. Biol. 25 (2005) 9608-9620
20. Kalapurakal J.A., Dome J.S., Perlman E.J., Malogolowkin M., Haase G.M., Grundy P., and Coppes M.J. Management of Wilms' tumour: current practice and future goals. Lancet Oncol. 5 (2004) 37-46
21. Raney R.B., Anderson J.R., Barr F.G., Donaldson S.S., Pappo A.S., Qualman S.J., Wiener E.S., Maurer H.M., and Crist W.M. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J. Pediatr. Hematol. Oncol. 23 (2001) 215-220
22. Rodriguez-Galindo C., Spunt S.L., and Pappo A.S. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med. Pediatr. Oncol. 40 (2003) 276-287
23. Lohrum M.A., Ludwig R.L., Kubbutat M.H., Hanlon M., and Vousden K.H. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3 (2003) 577-587
24. Dai M.S., Zeng S.X., Jin Y., Sun X.X., David L., and Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol. Cell. Biol. 24 (2004) 7654-7668
25. Zhang Y., Wolf G.W., Bhat K., Jin A., Allio T., Burkhart W.A., and Xiong Y. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell. Biol. 23 (2003) 8902-8912
26. Dai M.S., and Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 279 (2004) 44475-44482
27. Ziv Y., Bielopolski D., Galanty Y., Lukas C., Taya Y., Schultz D.C., Lukas J., Bekker-Jensen S., Bartek J., and Shiloh Y. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat. Cell Biol. 8 (2006) 870-876